or
Bookmark and Share
2.alpha.-Formyl-3.beta.-[(methoxalyl)oxy]-5-oxo-1.beta.-cyclopentanehepta noic acid and process
   
Document Number
US Patent 3992411
Issued Date
November 16, 1976
Link
Inventors
Map
Abstract
Racemic or optically-active prostaglandin E.sub.1 is synthesized from racemic or optically-active precursors in good yield at the various steps from 3.alpha., 6,7,7.alpha.-tetrahydro-4-methyl-2-oxo-1.beta.-indaneheptanoic acid methyl ester proceeding through 2.alpha.-(2-carboxyethyl)-3.beta.-hydroxy-5-oxo-1.beta.-cyclopentaneheptan oic acid methyl ester, .delta.-lactone, 5-cyclic ethylene acetal, 2.alpha.-(2-carboxy-2-formylethyl)-3.beta.-hydroxy-5-oxo-1.beta.-cyclopent aneheptanoic acid methyl ester, .delta.-lactone, 5-cyclic ethylene acetal, 2.alpha.-(2-carboxy-2-oxoethyl)-3.beta.-hydroxy-5-oxo-1.beta.-cyclopentane heptanoic acid methyl ester, .delta.-lactone, 5-cyclic ethylene acetal, and 3.beta.-hydroxy-2.alpha.-(3-oxo-1-octenyl)-5-oxo-1.beta.-cyclopentanehepta noic acid methyl ester, 5-cyclic ethylene acetal.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Owner
Merck & Co., Inc. (Rahway, NJ)
Published
November 16, 1976
Application Number
05/575,762
Filed
May 8, 1975
US Classification
549/342  
Int'l Classification
C07C   405/00   (20060101)  
Examiner
Parent Case
This application is a division of U.S. Ser. No. 435,812, filed Jan. 23, 1974, now U.S. Pat. No. 3,915,994, issued Oct. 28, 1975; which in turn is a division of U.S. Pat. Ser. No. 201,979, filed Nov. 24, 1971, now U.S. Pat. No. 3,833,612, issued Sept. 3, 1974.
USPTO Field of Search
260/34.9P  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us